Skip to main content
Erschienen in: Journal of Infection and Chemotherapy 6/2013

01.12.2013 | Original Article

Impact of intensive infection control team activities on the acquisition of methicillin-resistant Staphylococcus aureus, drug-resistant Pseudomonas aeruginosa and the incidence of Clostridium difficile-associated disease

verfasst von: Hiromichi Suzuki, Junko Senda, Keita Yamashita, Yasuharu Tokuda, Yohko Kanesaka, Noriko Kotaki, Hiroko Ishihara, Hiroichi Ishikawa

Erschienen in: Journal of Infection and Chemotherapy | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The transmission of multidrug-resistant organisms (MDROs) is an emerging problem in acute healthcare facilities. To reduce this transmission, we introduced intensive infection control team (ICT) activities and investigated the impact of their introduction. This study was conducted at a single teaching hospital from 1 April 2010 to 31 March 2012. During the intervention period, all carbapenem use was monitored by the ICT, and doctors using carbapenems inappropriately were individually instructed. Information related to patients with newly identified MDROs was provided daily to the ICT and instructions on the appropriate infection control measures for MDROs were given immediately with continuous monitoring. The medical records of newly hospitalized patients were reviewed daily to check previous microbiological results and infection control intervention by the ICT was also performed for patients with a previous history of MDROs. Compared with the pre-intervention period, the antimicrobial usage density of carbapenems decreased significantly (28.5 vs 17.8 defined daily doses/1000 inpatient days; p < 0.001) and the frequency of use of sanitary items, especially the use of aprons, increased significantly (710 vs 1854 pieces/1000 inpatient days; p < 0.001). The number of cases with hospital-acquired MRSA (0.66 vs 0.29 cases/1000 inpatient days; p < 0.001), hospital-acquired drug-resistant Pseudomonas aeruginosa (0.23 vs 0.06 cases/1000 inpatient days; p = 0.006) and nosocomial Clostridium difficile-associated disease (0.47 vs 0.11 cases/1000 inpatient days; p < 0.001) decreased significantly during the intervention period. Our study showed that proactive and continuous ICT interventions were effective for reduction of MDRO transmission.
Literatur
1.
Zurück zum Zitat Joo EJ, Kang CI, Ha YE, Kang SJ, Park SY, Chung DR, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome. Microb Drug Resist. 2011;17:305–12.PubMedCrossRef Joo EJ, Kang CI, Ha YE, Kang SJ, Park SY, Chung DR, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome. Microb Drug Resist. 2011;17:305–12.PubMedCrossRef
2.
Zurück zum Zitat Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect. 2011;79:359–63.PubMedCrossRef Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect. 2011;79:359–63.PubMedCrossRef
3.
Zurück zum Zitat Isobe M, Uejima E, Seki M, Yamagishi Y, Miyawaki K, Yabuno K, et al. Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother. 2012;18:841–7.PubMedCrossRef Isobe M, Uejima E, Seki M, Yamagishi Y, Miyawaki K, Yabuno K, et al. Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother. 2012;18:841–7.PubMedCrossRef
4.
Zurück zum Zitat Takata T, Miyazaki M, Li H, Healy M, Frye S, Tanaka K, et al. Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese university hospital between 1987 and 2004. J Infect Chemother. 2012;18:199–206.PubMedCrossRef Takata T, Miyazaki M, Li H, Healy M, Frye S, Tanaka K, et al. Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese university hospital between 1987 and 2004. J Infect Chemother. 2012;18:199–206.PubMedCrossRef
5.
Zurück zum Zitat Wenisch JM, Schmid D, Tucek G, Kuo HW, Allerberger F, Michl V, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2012;40:479–84.PubMedCrossRef Wenisch JM, Schmid D, Tucek G, Kuo HW, Allerberger F, Michl V, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2012;40:479–84.PubMedCrossRef
6.
Zurück zum Zitat Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.PubMedCrossRef Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.PubMedCrossRef
7.
Zurück zum Zitat Calfee DP, Salgado CD, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:62–80.CrossRef Calfee DP, Salgado CD, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:62–80.CrossRef
8.
Zurück zum Zitat Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:165–93.CrossRef Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:165–93.CrossRef
9.
Zurück zum Zitat Japanese Society of Environmental Infections. Position paper for the infection control of multidrug-resistant gram-negative bacteria, first edition. Jpn J Environ Infect. 2011;26:1–22.CrossRef Japanese Society of Environmental Infections. Position paper for the infection control of multidrug-resistant gram-negative bacteria, first edition. Jpn J Environ Infect. 2011;26:1–22.CrossRef
10.
Zurück zum Zitat Kac G, Grohs P, Durieux P, Trinquart L, Gueneret M, Rodi A, et al. Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria. Arch Intern Med. 2007;167:2086–90.PubMedCrossRef Kac G, Grohs P, Durieux P, Trinquart L, Gueneret M, Rodi A, et al. Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria. Arch Intern Med. 2007;167:2086–90.PubMedCrossRef
11.
Zurück zum Zitat Muder RR, Cunningham C, McCray E, Squier C, Perreiah P, Jain R, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2008;29702–8. Muder RR, Cunningham C, McCray E, Squier C, Perreiah P, Jain R, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2008;29702–8.
12.
Zurück zum Zitat Edwards R, Charani E, Sevdalis N, Alexandrou B, Sibley E, Mullett D, et al. Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review. Lancet Infect Dis. 2012;12:318–29.PubMedCrossRef Edwards R, Charani E, Sevdalis N, Alexandrou B, Sibley E, Mullett D, et al. Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review. Lancet Infect Dis. 2012;12:318–29.PubMedCrossRef
13.
Zurück zum Zitat Fishman N, Patterson J, Saiman L, Srinivasan A, Trivedi K, van Schooneveld T, et al. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012;33:322–7.CrossRef Fishman N, Patterson J, Saiman L, Srinivasan A, Trivedi K, van Schooneveld T, et al. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012;33:322–7.CrossRef
14.
Zurück zum Zitat Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43:971–8.PubMedCrossRef Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43:971–8.PubMedCrossRef
15.
Zurück zum Zitat Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother. 2012;67:802–9.PubMedCrossRef Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother. 2012;67:802–9.PubMedCrossRef
16.
Zurück zum Zitat Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42:1552–60.PubMedCrossRef Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42:1552–60.PubMedCrossRef
17.
Zurück zum Zitat Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR. Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. Am J Infect Control. 2010;38:350–3.PubMedCrossRef Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR. Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. Am J Infect Control. 2010;38:350–3.PubMedCrossRef
18.
Zurück zum Zitat Stone SP, Fuller C, Savage J, Cookson B, Hayward A, Cooper B, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ. 2012;344:e3005.PubMedCrossRef Stone SP, Fuller C, Savage J, Cookson B, Hayward A, Cooper B, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ. 2012;344:e3005.PubMedCrossRef
19.
Zurück zum Zitat Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum Beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55:1505–11.PubMedCrossRef Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum Beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55:1505–11.PubMedCrossRef
22.
Zurück zum Zitat Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136:834–44.PubMedCrossRef Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136:834–44.PubMedCrossRef
23.
Zurück zum Zitat Martinez-Capolino C, Reyes K, Johnson L, Sullivan J, Samuel L, Digiovine B, et al. Impact of active surveillance on methicillin-resistant Staphylococcus aureus transmission and hospital resource utilisation. J Hosp Infect. 2010;74:232–7.PubMedCrossRef Martinez-Capolino C, Reyes K, Johnson L, Sullivan J, Samuel L, Digiovine B, et al. Impact of active surveillance on methicillin-resistant Staphylococcus aureus transmission and hospital resource utilisation. J Hosp Infect. 2010;74:232–7.PubMedCrossRef
24.
Zurück zum Zitat Rodriguez-Bano J, Garcia L, Ramirez E, Lupion C, Muniain MA, Velasco C, et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol. 2010;31:786–95.PubMedCrossRef Rodriguez-Bano J, Garcia L, Ramirez E, Lupion C, Muniain MA, Velasco C, et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol. 2010;31:786–95.PubMedCrossRef
25.
Zurück zum Zitat Kang J, Mandsager P, Biddle AK, Weber DJ. Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting. Infect Control Hosp Epidemiol. 2012;33:477–86.PubMedCrossRef Kang J, Mandsager P, Biddle AK, Weber DJ. Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting. Infect Control Hosp Epidemiol. 2012;33:477–86.PubMedCrossRef
26.
Zurück zum Zitat Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19:1123–8.PubMedCrossRef Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19:1123–8.PubMedCrossRef
27.
Zurück zum Zitat Nakamura A, Miyake K, Misawa S, Kuno Y, Horii T, Kondo S, et al. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2013;83:153–5.PubMedCrossRef Nakamura A, Miyake K, Misawa S, Kuno Y, Horii T, Kondo S, et al. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2013;83:153–5.PubMedCrossRef
28.
Zurück zum Zitat Soeda H, Kaneko A, Inubuse A, Akashi T, Chiba K, Satoh K, et al. Effect of broad spectrum antimicrobial agents use monitoring policy on drug resistance in Pseudomonas aeruginosa. Jpn J Environ Infect. 2010;25:158–62.CrossRef Soeda H, Kaneko A, Inubuse A, Akashi T, Chiba K, Satoh K, et al. Effect of broad spectrum antimicrobial agents use monitoring policy on drug resistance in Pseudomonas aeruginosa. Jpn J Environ Infect. 2010;25:158–62.CrossRef
29.
Zurück zum Zitat Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect. 2006;64:7–15.PubMedCrossRef Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect. 2006;64:7–15.PubMedCrossRef
30.
Zurück zum Zitat Gilbert K, Stafford C, Crosby K, Fleming E, Gaynes R. Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs? Am J Infect Control. 2010;38:515–7.PubMedCrossRef Gilbert K, Stafford C, Crosby K, Fleming E, Gaynes R. Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs? Am J Infect Control. 2010;38:515–7.PubMedCrossRef
31.
Zurück zum Zitat Cohen B, Clock SA, Larson E, Behta M, Ross B, Saddul R, et al. Documentation of contact precautions in an electronic health record. J Nurs Care Qual. 2011;26:252–9.PubMedCrossRef Cohen B, Clock SA, Larson E, Behta M, Ross B, Saddul R, et al. Documentation of contact precautions in an electronic health record. J Nurs Care Qual. 2011;26:252–9.PubMedCrossRef
32.
Zurück zum Zitat Morikane K. Infection control in healthcare settings in Japan. J Epidemiol. 2012 5;22:86–90. Morikane K. Infection control in healthcare settings in Japan. J Epidemiol. 2012 5;22:86–90.
Metadaten
Titel
Impact of intensive infection control team activities on the acquisition of methicillin-resistant Staphylococcus aureus, drug-resistant Pseudomonas aeruginosa and the incidence of Clostridium difficile-associated disease
verfasst von
Hiromichi Suzuki
Junko Senda
Keita Yamashita
Yasuharu Tokuda
Yohko Kanesaka
Noriko Kotaki
Hiroko Ishihara
Hiroichi Ishikawa
Publikationsdatum
01.12.2013
Verlag
Springer Japan
Erschienen in
Journal of Infection and Chemotherapy / Ausgabe 6/2013
Print ISSN: 1341-321X
Elektronische ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-013-0621-x

Weitere Artikel der Ausgabe 6/2013

Journal of Infection and Chemotherapy 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.